91 completed, 20 terminated, 6 unknown, 3 withdrawn. 121 Phase 2, 21 Phase 3, 10 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 121 | Completed 91, Terminated 20, Unknown 6, Withdrawn 3, Recruiting 1 |
| Phase 3 | 21 | Completed 16, Unknown 5 |
| Phase 1 | 10 | Completed 6, Terminated 4 |
Follow Abbott: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries. Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets, Stratification and standard care - Myocardial Infarction, Acute, Myocardial Infarction With Nonobstructive Coronary Arteries | Phase 2 | Recruiting | NHS National Waiting Times Centre Board | 400 | 2022-02-04 | 2026-03-16 |
| The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo) - Inflammation | Phase 2 | Completed | University of Florida | 289 | 2016-04-26 | 2024-05-07 |
| Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction Bioabsorbable everolimus-eluting stent deployment - Impotence, Arteriogenic | Phase 2 / Phase 3 | Unknown | National Taiwan University Hospital | 15 | 2015-07-01 | 2015-07-08 |
| Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Creon IR, Creon® (DR/GR) - Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis | Phase 2 | Completed | Abbott | 70 | 2015-03-01 | 2016-04-04 |
| Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) MTX 12.5, MTX 25, Adalimumab - Ulcerative Colitis | Phase 2 | Terminated | Alimentiv Inc. | 22 | 2013-06-01 | 2021-06-23 |
| Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status Veliparib, Topotecan - Ovarian Cancer | Phase 1 / Phase 2 | Completed | Vejle Hospital | 22 | 2012-11-01 | 2015-06-10 |
| Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) everolimus, letrozole plus leuprolide, combination of everolimus, letrozole and leuprolide - Fibrolamellar Carcinoma, Fibrolamellar Liver Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 28 | 2012-07-12 | 2022-12-29 |
| EARNEST Rifabutin Pharmacokinetics (PK) Substudy Rifabutin - HIV, Tuberculosis | Phase 2 | Unknown | Justine Boles | 140 | 2011-12-01 | 2012-08-13 |
| Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Veliparib - Recurrent, Epithelial Ovarian Cancer | Phase 1 / Phase 2 | Completed | Vejle Hospital | 49 | 2011-11-01 | 2016-11-16 |
| Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Paricalcitol, placebo - Type 2 Diabetes | Phase 2 | Completed | Mario Negri Institute for Pharmacological Research | 112 | 2011-09-01 | 2017-03-03 |
| Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis Anti-tumor necrosis factor alpha monoclonal antibody, placebo - Uveitis, Juvenile Arthritis | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 34 | 2011-06-29 | 2025-09-08 |
| ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Adalimumab, Methotrexate, Placebo - Oligoarthritis | Phase 2 | Completed | University of Leeds | 22 | 2011-06-01 | 2019-11-07 |
| ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer ABT-888, mFOLFOX-6 - Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Georgetown University | 64 | 2011-01-03 | 2025-11-06 |
| Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut FITC-Adalimumab - Crohn's Disease | Phase 1 / Phase 2 | Completed | University of Erlangen-Nürnberg Medical School | 25 | 2011-01-01 | 2012-09-14 |
| Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Zemplar - Chronic Kidney Disease | Phase 2 / Phase 3 | Completed | Danderyd Hospital | 36 | 2010-09-01 | 2013-09-05 |
| ABT-888 and Temozolomide for Liver Cancer Temozolomide, ABT-888 - Hepatocellular Carcinoma | Phase 2 | Terminated | Georgetown University | 16 | 2010-08-01 | 2025-02-12 |
| To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors veliparib, Temozolomide - Solid Tumor Cancers | Phase 2 | Completed | Abbott | 24 | 2010-07-01 | 2012-11-21 |
| Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen ABT-263 - B-cell Chronic Lymphocytic Leukemia | Phase 2 | Withdrawn | Abbott | 150 | 2010-03-01 | 2010-02-26 |
| ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer ABT-888, temozolomide - Breast Cancer, Metastatic Breast Cancer | Phase 2 | Completed | Steven J Isakoff, MD, PhD | 63 | 2009-11-01 | 2025-03-14 |
| Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children palivizumab - Respiratory Syncytial Virus Infection, Premature Birth | Phase 2 / Phase 3 | Completed | Abbott | 100 | 2009-11-01 | 2011-07-19 |
Showing 20 of 121. Sign in to see all of them.
HIV Infections (15) · Psoriasis (7) · Crohn Disease (5) · Renal Insufficiency, Chronic (5) · Carcinoma, Non-Small-Cell Lung (4) · Dysmenorrhea (4) · Endometriosis (4) · Pelvic Pain (4) · Prostatic Neoplasms (4) · Alzheimer Disease (3) · Arthritis, Rheumatoid (3) · Attention Deficit Disorder with Hyperactivity (3) · Carcinoma, Renal Cell (3) · Dyspareunia (3) · Hyperparathyroidism, Secondary (3)
Adalimumab (22) · paricalcitol (11) · Lopinavir (8) · asoprisnil (8) · ABT751 (7) · Ritonavir (7) · lopinavir-ritonavir drug combination (7) · veliparib (7) · efavirenz (6) · pozanicline (5) · Temozolomide (4) · Valproic Acid (4) · Atrasentan (3) · Hydrocodone (3) · Lamivudine (3)
United States (64) · Canada (11) · Japan (10) · Germany (7) · France (6) · United Kingdom (6) · Italy (5) · Netherlands (5) · Spain (5) · Denmark (4) · Poland (4) · Puerto Rico (4) · Argentina (3) · Australia (3) · Brazil (2)
Helen Eliopoulos, MD (4) · Mihail Obrocea, MD (3) · Rita Jain, MD (3) · Rod Humerickhouse, MD (3) · Eugene Sun, M.D. (2) · Kathryn J Swoboda, M.D. (2) · Kazuko Kobayashi (2) · Shigeki Hashimoto, Ph.D. (2) · Aiwu R He, MD PhD (1) · Anders Jakobsen, DMSc (1) · Anders Jakobsen, MD, DMSc (1) · Barbara A da Silva, M.D. (1) · Barbara da Silva, M.D. (1) · Beatrice Rendenbach-Mueller, PhD (1)
PMID 22325170, PMID 27338778, PMID 29380251, PMID 17307170, PMID 17339234, PMID 18018771, PMID 18434903, PMID 18540803, PMID 18576337, PMID 19512937, PMID 20186346, PMID 20808854, PMID 21055801, PMID 21346607, PMID 21748252, PMID 21754985, PMID 22344964, PMID 22913981, PMID 22943074, PMID 23147218, PMID 23247938, PMID 23504383, PMID 23686466, PMID 23766338, PMID 23787544, PMID 24476416, PMID 24746976, PMID 24751453, PMID 24874893, PMID 25486412, PMID 25838291, PMID 25973909, PMID 26449224, PMID 26496210, PMID 26547918, PMID 26977746, PMID 27136622, PMID 28511692, PMID 29104158, PMID 29275333, PMID 29386411, PMID 29579325, PMID 29767684, PMID 30104007, PMID 30541065, PMID 30608620, PMID 30968368, PMID 31370809, PMID 33270906, PMID 34417675
2008 (3), 2005 (1), 2009 (1), 2014 (1), P30AI050410 (1), R01AI064074 (1), U01AG050499 (1), U01AI067854 (1)